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Background: Breast cancer accounts for almost 30% of all cancers and is the second leading cause of cancer
deaths in women in Scotland. Screening is key to early detection. The Scottish Breast Screening Programme is a
nationwide, free at point of delivery screening service, to which all women aged between 50 and 70 years are
invited to attend every 3 years. Currently over three-quarters of invited women regularly attend screening. However,
women from more deprived areas are much less likely to attend: for example in the 3 years from 2010–2012 only
63% of women in the most deprived area attended the East of Scotland Breast Screening programme versus 81%
in the least deprived. Research has suggested that reminders (telephone or letter) and brief, personalised interventions
addressing barriers to attendance may be helpful in increasing uptake in low-income women.
Methods/Design: We will employ a brief telephone reminder and support intervention, whose purpose is to elicit
and address any mistaken beliefs women have about breast screening, with the aim that the perceived benefits of
screening come to outweigh any perceived barriers for individuals. We will test whether this intervention, plus a simple
anticipated regret manipulation, will lead to an increase in the uptake of breast cancer screening amongst low-income
women who have failed to attend a first appointment, in a randomised controlled trial with 600 women. Participants
will be randomly allocated to one of four treatment arms i.e. 1) Letter reminder (i.e. Treatment as usual: CONTROL); 2)
Telephone reminder (TEL), 3) Telephone reminder plus telephone support (TEL-SUPP) and 4) Telephone reminder plus
support plus AR (TEL-SUPP-AR). The primary outcome will be attendance at breast screening within 3 months of the
reminder letter.
Discussion: If this simple telephone support intervention (with or without AR intervention) leads to a significant
increase in breast screening attendance, this would represent a rare example of a theoretically-driven, relatively simple
psychological intervention that could result in earlier detection of breast cancer amongst an under-served group of
lower socio-economic women.
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The problem
The National Health Service (NHS) Breast Cancer Scree-
ning Programme is a national organised screening pro-
gramme which runs throughout the UK. In Scotland,
there are six main breast screening centres including
the East of Scotland Breast Screening Service, based in
Dundee. Currently, all women aged between 50 and 70
years are called or re-called for screening on a 3-yearly
basis; invitations are generated according to General Prac-
titioner (GP) practices. Women aged over 70 years are not
recalled automatically but can request screening. Screen-
ing is via mammography: a low-dose X-ray used to detect
very early tumours, which are too small to be felt. In the
East of Scotland region, approximately 95% of women
screened have a normal mammogram and 5% are recalled
for further tests at an assessment clinic (including special-
ist X-rays, ultrasound, core biopsies); only 1 in 8 of those
recalled will be found to have cancer.
Screening uptake
In 2007/8, 16,515 women were invited to attend the East
of Scotland Breast Screening service and 12,970 (78.5%)
attended, with 611 (5.2%) being referred to the assess-
ment clinic. For the whole region, this attendance rate is
higher than the average across Scotland. However, wo-
men from more deprived areas are much less likely to
attend for screening: for example in the 3 years from
2010–2012 only 63% of women in the most deprived
area attended versus 81% in the least deprived. This pat-
tern has changed little since the service began.
Benefits of increasing screening
Screening, alongside improvements in treatment, has al-
most certainly contributed to the fall in deaths from
breast cancer in Scotland in the last 20 years (e.g. a
32% reduction between 1990 and 2008 in the 50–69 age
group). However, women in the most deprived areas
continue to have the worst breast cancer survival rates.
Millar [1] predicted that, if screening uptake for all
Scottish Index of Multiple Deprivation (SIMD) quintiles
could be increased to the highest observed rate, 49–57
extra cancers would be detected in Scotland annually,
with an extra 7–33 lives saved. However, it should be
noted that this increase could also lead to up to 1316
false positive screens (which turn out to be clear after
further diagnostic tests) and 66 over-diagnoses; the latter
may result in women receiving treatment for a slow-
growing or non-invasive cancer which was unlikely to
have caused them any problems if left untreated. Although
the numbers of additional cancers detected appear fairly
small, the survival rate of patients with early-detected
breast cancer via routine screening is approximately dou-
ble that from cancers detected via other methods [2].Existing interventions to increase breast screening uptake
A number of reviews of interventions to increase uptake
of breast cancer screening both within and outwith or-
ganised screening programmes have been undertaken
[3-5]. Few of the interventions covered by these reviews
were conducted in the UK, although some did target
low-income or socially disadvantaged women. Many of
the reviewed interventions are reported to be of poor
quality and there is insufficient evidence for the effect-
iveness of many of the chosen approaches including pa-
tient incentives, mass media alone (e.g. public health
promotions) and group education. Providing low-income
women with detailed medication explanations was not
found to be helpful, and may even deter women from
attending.
Despite these limitations, there was broad agreement
among the reviews that reminders (either letter or tele-
phone) can increase uptake rates amongst all groups. Re-
moving practical barriers, such as making screening more
accessible and reimbursing travel expenses may also be
helpful to lower socio-economic groups. Having GPs more
involved, and providing tailored one-to-one education
messages that address individual barriers to screening may
also increase uptake in low-income women [3-5]. How-
ever, although the latter may be effective, such tailored
interventions need direct contact and knowledge of wo-
men’s beliefs and attitudes and may be expensive to carry
out on a large scale.
Theoretical background
Addressing barriers and concerns
Believing breast cancer screening to be worthwhile, and/
or intending to go for screening, does not always trans-
late into actual attendance. The Health Belief Model [6]
suggests that the likelihood of engaging in a particular
health preventive behaviour, such as attending breast
screening, is influenced by the perceived benefits of that
behaviour in relation to the perceived barriers to carry-
ing out the behaviour, alongside perceptions of risk and
the severity of the targeted illness. Women express a
range of barriers to attending breast screening, including
lack of knowledge or concerns about the efficacy of scree-
ning, anxiety and fear (of the process e.g. pain or the out-
come e.g. cancer), embarrassment, practical difficulties
such as getting time to attend (e.g. time off work, or from
being a carer), cost of transport and difficulties of parking
[7]. Many of these barriers are particularly salient to
women from socially-deprived areas.
A recent qualitative review of participation in the free,
nationwide ‘BreastScreen Australia’ service, which exam-
ined both facilitators and barriers to attending screening,
found that women expressed both ‘active’ and ‘passive’
barriers to attendance [8]. ‘Active’ barriers tended to be
found amongst higher socio-economic women, who had
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ded that mammograms were ‘unnecessary’, for instance
thinking they might be harmful (e.g. radiation) and that
they were not necessarily efficacious (e.g. citing the oc-
currence of cancers found between screenings). Lower
socio-economic women were more likely to express ‘pas-
sive’ barriers to non-attendance (e.g. low awareness of
the benefits, other demands making it difficult to attend,
and practical barriers to attendance). For many women,
there wasn’t a single major barrier which prevented them
attending, rather there appeared be a cumulative effect of
several barriers which tipped the balance towards non-
attendance. The authors observed that facilitators to at-
tendance included a belief that the benefits outweighed
the barriers to attendance: for example, regular attenders
expressed pain as a deterrent as often as non-attenders,
but seemed to accept that the benefits of screening
outweighed this short-lived negative effect. The report
concluded that: ‘the benefits of screening need to be
reinforced and women reminded that these outweigh
the barriers, even though the downsides may seem
more numerous and immediate’ [8], p.62.
In a previous study, in which we aimed to address
non-adherence to medication in stroke patients [9], a
tailored intervention sought to elicit and address pa-
tients’ medication concerns, by providing relevant and
tailored information to address any erroneous beliefs
they may have held, which could act as barriers to taking
their medication. The aim was to ensure that patients’
beliefs in the necessity of their medication came to out-
weigh any perceived concerns that they had. We had pre-
viously conducted a qualitative study to identify barriers
[10], and used the output from this, plus additional in-
put from stroke doctors, to develop a list of potential re-
sponses which would help address these concerns and
assist patients to overcome any barriers reporteda. Practi-
cal issues of medication-taking, e.g. forgetting, were also
addressed by getting patients to state and write down
regular plans for taking their medication. This interven-
tion was successful at both increasing the regularity of
pill-taking (by 10%), and also reducing concerns about
stroke medication, such that at follow-up patient’s views
in the necessity of their medication came to outweigh
their concerns.
A recent small, pilot study which conducted a brief
telephone coaching intervention to address barriers to
breast cancer screening uptake in under-served women
in the US used a similar approach [11]. This intervention
addressed both benefits and barriers regarding screening,
for instance, by seeking to increase individuals’ beliefs in
the importance of early detection, and provided sug-
gestions on how to overcome personal barriers, such as
transportation issues or fear. They found an increase in
re-arranged appointments, with almost 95% of womenin the intervention group re-scheduling, and 8% more
women in the intervention group attended their new ap-
pointment compared to the control group (54% versus
46%). The authors suggested that one way of reaching
and addressing the psychosocial issues which prevent
low-income women from attending breast screening is
via brief, tailored interventions conducted within a tele-
phone reminder. Telephone contact requires fewer re-
sources than face-to-face tailored interventions, and could
practicably be delivered within an NHS context, particu-
larly if it is targeted only at non-attenders.
We therefore propose that a brief telephone interven-
tion to elicit and address concerns about breast screen-
ing, with the aim of ensuring that a woman’s belief in
the benefits of breast screening come to outweigh any bar-
riers or concerns, could be effective at increasing screen-
ing attendance amongst low socio-economic women.
Anticipated regret
Regret is a negative cognitive-based emotion that is ex-
perienced when we imagine that the present situation
could have been better had we acted differently. It is also
possible to anticipate regret and thus act to, or prepare
to, avoid actually experiencing this unpleasant emotion.
Anticipated regret (AR) has been shown to add signifi-
cantly to the prediction of intentions and prospective
health behaviours, over and above the traditional attitu-
dinal components of influential social cognitive theories
such as the Theory of Planned Behaviour (TPB) (see re-
view by Abraham & Sheeran [12]). In an AR manipula-
tion in cervical cancer screening, Sandberg and Conner
[13] randomised women due to be invited for screening
to one of three groups: 1) a control group, 2) a group
sent a TPB questionnaire and 3) a group who were asked
to complete a TPB questionnaire, as well as answering
two AR questions on a Likert-style 7 point scale; “If I
did not attend for a cervical smear in the next few weeks
I would feel regret”, and “If I did not attend for a cer-
vical smear in the next few weeks, I would later wish I
had”. Overall screening attendance was 21%, 26% and
26% in the control group, TPB group and TPB + AR
groups respectively (i.e., simply sending out a question-
naire increased attendance by 5%). For those who com-
pleted and returned the questionnaire, the attendance
rates were 21%, 44% and 65% respectively; thus a subtle
AR intervention significantly increased the likelihood of
intention to attend screening being translated into actual
attendance. This is an impressive effect, given the sim-
plicity, low cost and low intensity of the intervention.
Subtly increasing the prominence of AR in the decision-
making process emphasises the aversive emotional conse-
quences of not taking action, and the desire to avoid the
negative feeling of regret then motivates people to trans-
late their positive intentions into action, because failing to
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also evidence that using interventions which target emo-
tions rather than cognitive processes (such as education
or providing detailed information) may be more effective
with low-income groups [14]. It is likely that higher socio-
economic individuals may be better able to evaluate facts
or evidence, whereas those from lower socio-economic
groups may be more prone to use emotions to guide their
decision-making. As illustrated by Sandberg and Conner
[13], the concept of AR seems particularly relevant to the
context of cancer screening, as not taking part in screen-
ing and then later being diagnosed with cancer is likely to
lead to marked feelings of regret.
Based on the approach of Sandberg and Conner [13],
we are currently testing an AR intervention in a large-
scale, questionnaire-based study with 60,000 people in-
vited to take part in the Scottish Bowel Cancer Screening
programme where patients are sent Faecal Occult Blood
Testing kits, to complete at home [15]. We are predicting
that AR will be related to a greater uptake in test kit re-
turn across all socio-economic groups.
We therefore propose that a similar AR manipulation
may also increase breast cancer screening rates among
low socio-economic women.
Pilot studies
Factors associated with poor uptake in low-income women
in Tayside
A small qualitative survey, aimed at eliciting factors
associated with low uptake in low-income women, was
previously conducted in NHS Tayside [16]. Women from
two GP practices in low-income areas who had failed to
attend their most recent screening appointment were
invited to attend focus groups in a local community
centre; participants were reimbursed £10 for expenses/
inconvenience. Eleven women agreed to take part in 2
focus groups and 7 attended. Some of the women sug-
gested they had been screened on at least one previous
occasion; thus this small, self-selected sample is unlikely
to represent those most resistant to attending breast
screening. Millar therefore proposed that “future work
to encourage non-attenders to share their reasons for
not attending utilising other methods such as telephone
interview or questionnaire may prove effective in gaining
the views of a wider group”.
Nonetheless barriers to breast screening emerging from
the focus groups mirrored those found in other research
e.g. [7]. These included: fear and anxiety (e.g. of the pro-
cess, potential outcome, radiation levels, waiting for re-
sults), life issues (e.g. being carers or working and finding
it hard to get away, poor health) and access (e.g. transport,
parking, location, weather). Participants also suggested
that reminders, peer-led support and advice, and more
mobile units might be helpful. The themes from the focusgroups were reviewed with staff at the breast screening
service, and there was frequent concordance with the rea-
sons expressed by the non-attending women. The barriers
generated from this research will be used as the basis for
eliciting and addressing barriers and concerns in the
current study.
Anticipated regret (AR)
As outlined above, we are currently conducting an AR
intervention study in colorectal cancer screening [15].
This research will test whether adding two AR questions
to a simple questionnaire significantly increases screening
uptake in people from all social deprivation categories. In
a different context, we have also shown that the simple
AR manipulation that we propose using here led to a sig-
nificant increase in intention to become an organ donor
[17] and self-reported organ donor registration [18].
Aims
Our aim is to elicit and address barriers and facilitators
to breast screening attendance in low socio-economic
women via a brief, personalised, telephone intervention,
aimed at increasing screening uptake. We will also test
whether asking questions about anticipated regret (AR)
leads to additional increases in screening uptake; and
examine whether this brief intervention is feasible and
acceptable to low-income women.
Research questions
1. Is a simple, telephone reminder intervention, aimed
at eliciting and addressing the barriers and concerns
of women in socially-deprived areas regarding
attending screening at the East of Scotland Breast
Screening Service, feasible and acceptable to
participants?
2. Can this brief, telephone intervention increase
uptake in non-attenders from socially-deprived
areas?
3. Does adding anticipated regret to the telephone
intervention have any additional benefit in terms of
increasing uptake of screening in non-attenders?
Methods/Design
We will adopt a simple, between-groups, four-arm pro-
spective RCT design. The intervention will be targeted
at those who are due to be sent a reminder letter i.e.
non-attenders at a scheduled appointment. The four
arms are: 1) Letter reminder (i.e. Treatment as usual:
CONTROL); 2) Telephone reminder (TEL), 3) Tele-
phone reminder plus telephone support (TEL-SUPP)
and 4) Telephone reminder plus telephone support plus
AR (TEL-SUPP-AR). The CONSORT diagram is shown
in Figure 1.
Non-attenders at the 
East of Scotland Breast 
Screening Service, in 
Scottish Index of Multiple 
Deprivation vigintiles 1-12
Randomised (n = 600)
Reminder letters
CONTROL
(n = 150)
Telephone reminder
TEL 
(n = 150)
Telephone support
TEL-SUPP 
(n = 150)
Receive
a) standard 
reminder letter
Receive
a) standard reminder 
letter
b) Brief telephone 
reminder
Receive
a) standard 
reminder letter
b) Brief telephone 
reminder
c) Telephone 
support to address 
barriers
Attendance at 
screening
Attendance at 
screening
Attendance at 
screening
Analysed as 
allocated
Analysed as 
allocated
Analysed as 
allocated
Enrolment
Allocation
Intervention
Analysis
Telephone support
TEL-SUPP-AR 
(n = 150)
Receive
a) standard 
reminder letter
b) Brief telephone 
reminder
c) Telephone 
support re: barriers
d) AR intervention
Attendance at 
screening
Analysed as 
allocated
Outcome
Figure 1 CONSORT diagram of study design. Note: Scottish Index of Multiple Deprivation vigintiles 1-12 represent the highest 60% of areas of
deprivation in Scotland (based on postcode area).
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A single-centre trial based at the East of Scotland Breast
Screening Centre, located within NHS Tayside in Dundee,
Scotland.
Ethical approval
Ethical approval has been granted by Tayside NHS Board,
East of Scotland Research Ethics Committee REC 1 (ref.
no. 13/ES/0128).
Recruitment
Participants will be selected from those receiving an ap-
pointment for breast screening who do not telephone to
cancel or re-arrange their appointment and who fail to
attend their appointment before the reminder letter is
due to be sent. Sampling will be from the lists of women
for whom reminder letters are generated. We plan to tar-
get women from lower socio-economic areas, specifically
women from Scottish Index of Multiple Deprivation(SIMD) vigintiles 1–12 (representing the lowest 60% of
socio-economic areas in Scotland)b. The Scottish Index of
Multiple Deprivation assesses deprivation levels for small
geographical areas, based on income, employment, health,
education, skills and training, housing, geographic access
and crime. Based on the numbers of women who did
not attend their designated appointment at the East
of Scotland Breast Screening Service during 2012, we
estimate that in 6 months we could recruit approximately
1,030 women. Currently the screening database does not
include a telephone number for all women. We will there-
fore seek to obtain this information from other data
collections (see Telephone numbers below). We would
achieve our target for randomisation of 600 women, who
are contactable by telephone, providing we are able to ob-
tain approximately 58% of telephone numbers. We will
seek to obtain telephone numbers before randomisation,
so there is no bias in the Control group (for whom we do
not require telephone numbers).
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Telephone numbers are not currently held on the scree-
ning database. Some patients may have telephone details
on the local hospital administration system and this will
be searched in the first instance for phone numbers.
Subsequently online and past and present paper tele-
phone directories will be used to try and obtain num-
bers, where possible. We would therefore aim to include
significantly more participants than required for analysis
to account for the likelihood of having a large number
of non-contactable women, and have chosen the SIMD
vigintiles used to reflect this need. This would be moni-
tored throughout the project, and if necessary (for in-
stance if we were able to obtain more or fewer phone
numbers than predicted), the SIMD range could be con-
tracted or widened, as appropriate. The feasibility of ob-
taining telephone numbers is an important secondary
outcome of this proposed research.
Inclusion criteria
Sampling will be via the list of women who are due to
be sent a reminder letter for a missed breast screening
appointment, and who have not telephoned to cancel or
rearrange their appointment. From this list, we will in-
clude all women residing in SIMD vigintiles 1–12, for
whom telephone numbers can be obtained.
Exclusion criteria
We will exclude participants who appear to have diffi-
culty understanding the verbal information presented
about the study and/or appear to be incapable of decid-
ing to give consent, when telephoned. (If there is any
doubt about this, then the participant will be excluded.)
This will include people who have difficulty understan-
ding the English language. Women expressing a desire
not to take part due to existing illness which may pre-
clude their attending breast screening (e.g. breast cancer)
would also be excluded. There are no other exclusion
criteria.
Informed consent
To preserve anonymity, no information will be given out
about the nature of the phone call, until the Research
Fellow is certain they are talking to the correct person.
Verbal informed consent will be obtained at the begin-
ning of the telephone support intervention, for those
participants who affirm they are willing to be asked a
few questions about breast screening. (Those who de-
cline to answer any questions will be deemed to have re-
fused consent and will not be contacted further.)
First, the purposes of the study will be read from a
Patient Information Sheet. It will be made clear that the
researcher is completely independent of the breast screen-
ing service and the participant's decision to participate (ornot) will not affect their future treatment and that confi-
dentiality of all their answers will be ensured. The partici-
pant will then be asked whether they consent to take part
in the intervention.
Although we are not seeking written consent from
intervention participants, patients' responses to the con-
sent question will be recorded on a datasheet, and those
refusing consent will be excluded from the study and
will have no further contact from the researchers. Con-
sent to tape-record the interview will also be sought;
however, refusal to be recorded will not result in exclu-
sion. Prospective participants who feel unable to decide
immediately whether to take part will be given the op-
tion to be called back later, once they have had time to
consider. They will also be referred to an independent
researcher, if they would prefer to talk to someone else
regarding the research. Participants who feel unable to
decide will also be given the option of being posted the
Information Sheet; and a follow-up telephone call will be
arranged, to see whether they have decided to take part.
Due to the design of our study, in which it is impera-
tive that the telephone intervention is conducted as
close to the posting of the reminder letters as possible to
ensure parity of timing with the control and three tele-
phone intervention groups, and to reduce the possibility
that participants will already have rearranged their ap-
pointment before being telephoned, we are unable to
seek written consent from participants. However, we be-
lieve that we have addressed any concerns about this by
having the Research Fellow read the Information Sheet
to all participants, as well as allowing prospective partic-
ipants the opportunity to take time to reflect on taking
part, speak to an independent person and/or to be posted
the information sheet.
We are not seeking consent to collect follow-up at-
tendance data from any participants for the following
reasons: this would be impracticable for the control
group; and for the three telephone groups, informing
them that we would be checking their future attendance
would in itself constitute an intervention, thereby con-
founding our true intervention, and precluding direct
comparison with the control group. This would have the
effect of rendering our results scientifically meaningless.
Not seeking consent for collection of data on screening
uptake is an approach previously used in a number of
previous studies with cancer screening, all of which have
gained ethical approval from UK National Health Service
(NHS) Ethics Research Committees (i.e. colorectal can-
cer screening [15,19]; cervical cancer screening: [13]).
We feel this approach is justified in the current research
for the following reasons: (a) no harm will come to the
participants from our collecting screening data, (b) our re-
search cannot be practically carried out if we had to
receive written informed consent from all participants,
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effective methods of increasing breast screening in
Scotland) outweigh any cost, (d) the East of Scotland
Breast Screening Service already have access to the at-
tendance data and (e) no individual identifiable results
will be recorded in the database for analysis.
All data for analysis will be completely anonymised
and confidential. Staff at the East of Scotland Breast
Screening Centre will not see any data from the tele-
phone intervention, and staff at the University of Stirling
will not record any personally identifiable information
on patients alongside the intervention data: the two
datasets will be linked by an anonymised unique identi-
fying code. We therefore believe we have taken all ne-
cessary steps to eliminate any risk to participants in the
current study which may arise from their not giving in-
formed consent for collection of attendance data. In-
formed consent will be obtained for participation in the
telephone support intervention.
We have obtained full UK NHS IRAS ethical approval
for this approach (Tayside NHS Board, East of Scotland
Research Ethics Committee REC 1 (ref. no. 13/ES/0128).
Design
We will adopt a simple, between-groups, four-arm pro-
spective RCT design. Participants will be sampled from
women who have failed to attend their recent appoint-
ment for breast screening. Women who have telephoned
to decline or rearrange their screening appointment will
be excluded. The intervention will be targeted at lower
income women i.e. those from SIMD vigintiles 1–12.
The four treatment groups are: 1) Letter reminder (i.e.
Treatment as usual: CONTROL); 2) Telephone remin-
der (TEL), 3) Telephone reminder plus telephone support
(TEL-SUPP) and 4) Telephone reminder plus support plus
AR (TEL-SUPP-AR).
Letter reminder group (CONTROL)
Participants randomised to the Control group will re-
ceive the reminder letter only, as current practice. This
will be sent from the East of Scotland Breast Screening
Centre.
All telephone groups (TEL, TEL-SUPP, TEL-SUPP-AR)
All telephone groups will receive the standard reminder
letter in the same manner as the Control group. Partici-
pants in each of the three telephone groups will also be
telephoned by the Research Fellow from the University
of Stirling within two weeks of the reminder letter being
posted. Telephone calls will be tape-recorded in order to
check the fidelity of the intervention, and also to ensure
accuracy of the participant’s answers recorded on the
check-list. Participants who opt not to allow their calls
to be recorded will still be able to take part in theintervention. Participants who do not answer or are not
at home when telephoned, would be called on a max-
imum of 5 occasions, after which they would be re-
corded as non-contactable.Telephone reminder group (TEL)
The telephone reminder (TEL) will be a simple tele-
phone call to remind non-attenders that they did not
attend their scheduled appointment and provide infor-
mation on how they can rearrange this appointment.
Women wishing to rearrange their appointment will
be given the option of being transferred directly to the ap-
pointments service at the Breast Screening Centre in
Dundee.Telephone support groups (TEL-SUPP and TEL-SUPP-AR)
Participants who are allocated to the telephone support
intervention arms (TEL-SUPP and TEL-SUPP-AR) will
be told that we are trying to understand why some wo-
men do not take up their invitation to attend for breast
screening when invited and asked whether they would
be prepared to answer some questions about breast
screening. Those declining at this point would be as-
sumed to have not given consent and would not be con-
tacted further. The Patient Information Sheet will then
be read out to prospective participants. This explains the
nature and purpose of this research and reassures partic-
ipants about the confidentiality and anonymity of their
responses. They will be asked if they have any questions
about our research and, if yes, will also be given the op-
tion of being able to talk to a Health Psychologist, who
is independent of this research. They will be asked whe-
ther they agree to take part now (Yes/No), or whether
they would prefer to be phoned back later.
In both telephone support arms (TEL-SUPP and TEL-
SUPP-AR), patients will be asked to describe any reasons
they had for not taking up the invitation to attend their
appointment, and where appropriate, any barriers they
mention will be addressed using a pre-specified list of
responses, which will be generated from previous re-
search (e.g. other women have mentioned that difficulty,
but they managed to get over it by…. (How) could that
work for you?’). Any patient queries or concerns about
the process of breast screening will also be addressed,
using responses from existing materials. Whether or not
specific barriers are mentioned by individuals will be
recorded on a check-list of barriers generated from the
existing research and previous telephone interviews.
Any additional barriers mentioned will be added to this
check-list.
Participants in the TEL-SUPP and TEL-SUPP-AR groups
would also be asked to say whether they now intended to
make an appointment to attend for breast screening: ‘Do
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‘Yes’, ‘No’, ‘Maybe’ or ‘Don’t know’.
Participants will be reassured throughout that it is
their choice whether or not to take up their invitation to
attend breast screening, but that the researcher is there
to seek their views on attending and to provide them
with additional help and information, should they wish
to make another appointment to attend.
In order to check the acceptability and feasibility of
the telephone support intervention, participants will be
asked whether they minded being phoned up about
breast screening, and also whether they found the tele-
phone call helpful in addressing any concerns, queries or
issues they might have regarding attending breast
screening (‘Yes’, ‘No’, ‘Maybe’ or ‘Don’t know’).
It is envisaged each phone call would last 5–10 mi-
nutes, although some may take longer, if a participant
has a lot of issues she wants to discuss, and some would
be shorter, if the participant does not mention any bar-
riers or does not wish to take part. Women who express
a desire to rearrange their appointment will be given the
option of being transferred directly to the appointments
service at the Breast Screening Centre in Dundee at the
end of the telephone intervention.
Telephone support plus anticipated regret only
(TEL-SUPP-AR)
In the TEL-SUPP-AR group, participants will receive
exactly the same intervention as the TEL-SUPP condition,
with the addition of two questions relating to Anticipated
Regret, ‘If you didn’t make another appointment to attend
for breast screening, would you later wish you had?’; ‘If
you didn’t attend for breast screening, would you later re-
gret it?’ Participants would be asked to respond ‘Yes’, ‘No’,
‘Maybe’ or ‘Don’t know’. These questions would be asked
at the end of the support intervention, immediately before
the question relating to intention to attend screening.
Training materials
Detailed training materials will be produced by the Re-
search Fellow, based on the techniques and materials
used in the telephone intervention. This will enable the
intervention to be subsequently conducted by NHS staff.
Sampling and randomisation
Participants will be selected from those receiving an ap-
pointment for breast screening who do not telephone to
cancel their appointment and who fail to attend or to re-
arrange their appointment before the reminder letter is
due to be sent. Sampling will be from the lists of women
for whom reminder letters are generated. Postcodes will
be used to derive Scottish Index of Multiple Deprivation
(SIMD) vigintiles, and women who are from a SIMD vig-
intile between 1 and 12 inclusive (where 1 represents themost deprived areas), for whom telephone numbers can
be obtained, will be randomised to treatment arm in a
1:1:1:1 ratio.
In order to achieve a balance between treatment
groups, randomisation will be carried out by a member
of the research team who is independent of the interven-
tion on a record by record basis using minimisation via
the MINIM software program [20] with age band (50–
56, 57–63, 64 or older) and SIMD quintiles (i.e. 1, 2, 3
equivalent to vigintiles 1–4, 5–8 and 9–12) as the mini-
misation variables. The minimisation algorithm allocates
the first record randomly and subsequent participants
are allocated to minimise the imbalance between groups
on the minimisation variables. It is currently the best
available method of achieving randomisation whilst “en-
suring excellent balance between groups for several prog-
nostic factors, even in small samples” [21]. To ensure that
the researcher does not influence the randomisation pro-
cess, participants will be entered into the MINIM software
sequentially, according to their order in the reminder let-
ter list and the researcher will also remain blind to the
identity of each treatment group (i.e. by randomising only
to A, B, C, or D) during the randomisation process. The
same researcher will collect the three-month follow-up
data and carry out the data analysis and will continue to
remain blind to the identity of each treatment group until
this is complete.
Data collection and security
The Research Fellow will require access to patients' per-
sonal details to enable contact by telephone. Only the
minimum information required for contact will be re-
corded. Any personal information will be stored separ-
ately from data collected at interview. All information
will be kept either on a secure network computer and/
or in a locked filing cabinet, in a locked office, at the
University of Stirling.
A unique anonymised identifier will be used to enable
matching with the follow-up attendance data. The follow-
up attendance data will be collected from the screening
database on-site at the Breast Screening Centre, 3 months
after the reminder intervention. The anonymised data
from the telephone interventions and attendance screening
data will be stored on a secure password-protected net-
work server computer and analysed by the Research Fellow
at the University of Stirling. Data integrity will be enforced
by cross-checking with the recorded interview after the
intervention is complete and by valid value and range
checks at the time of data entry. Data storage systems at
the University are built to be resilient to failure; their loca-
tions have secure physical entry and protected power sup-
plies and are guarded by fire and intruder alarms. Data will
be kept for a period of 10 years, in line with University
Policy, after which it will be securely destroyed.
Chambers et al. BMC Public Health 2014, 14:824 Page 9 of 10
http://www.biomedcentral.com/1471-2458/14/824Primary and secondary outcomes
The primary outcomes, collected at 3-month follow-up,
will be whether or not each patient makes another ap-
pointment for breast screening and whether or not they
attended screening within 3 months of receiving their
reminder (letter or telephone call). Previous attendances
and previous failures to attend (attendance history) will
also be collected at this time. Secondary measures for
the two telephone support arms, collected during the
telephone interview, are intention to make another ap-
pointment, anticipated regret, number of barriers to breast
screening mentioned by participants, and specific barriers
reported. In addition the percentage of participants for
whom telephone numbers are obtainable at the outset is
an important secondary outcome.Analysis
Our primary analysis will be chi-square to detect diffe-
rences in the proportion of respondents who attended
breast screening within 3 months of the reminder letter
or call as a function of the 4 arms (control, TEL, TEL-
SUPP or TEL-SUPP-AR). This will be followed by logis-
tic regression of attenders versus non-attenders in the
four groups, controlling for potential between-arm dif-
ferences in age, social deprivation (SIMD) and history
of previous breast screening attendance. Our primary
analysis will be on an ‘Analysed as Allocated’ basis, i.e.
including all participants, whether or not they were
successfully contacted by telephone and/or agreed to
take part in the study. Secondary analysis will be con-
ducted for those agreeing to and participating in the
intervention (TEL-SUPP and TEL-SUPP-AR groups only)
to test the mediating and moderating roles of reported
barriers, intention and AR in uptake of screening after
reminder.Power calculations
A power calculation indicates that a sample of 600 par-
ticipants would provide 80% power (at the 5% level) of
detecting an increase of 11% in the TEL-SUPP and TEL-
SUPP-AR groups versus no increase in the Control group
and a 3% increase in the telephone reminder group (TEL),
assuming a base attendance rate of around 69% (as cur-
rently present in vigintiles 1–12). This would also equate
to 67% power (at 5% level) of detecting an increase in up-
take of 9% spread across the 3 telephone intervention
arms versus the Control group.Evaluation
The effects of the intervention will be evaluated via meas-
urement of the primary and secondary outcome variables
listed above.Process evaluation
As this study is based on a one-off telephone call no
process evaluation is required.
Timetable
This is a 17-month project. Months 1–3 will be spent
designing the telephone support intervention and devel-
oping the barriers checklist and recruitment procedures.
During this period we shall obtain IT approval for the
Research Fellow to access the required databases, as well
as Caldicott approval for the data extraction. The Re-
search Fellow will also gain an NHS Tayside ‘letter of ac-
cess’, which permits access to the required data systems,
for the duration of the study.
Months 4–9 will be spent conducting the telephone
intervention. We plan a sample size for analysis of 600;
with 450 women randomised to the three telephone in-
terventions, this equates to around 75 telephone calls
per month.
We require a three-month lag after the intervention to
collect data on screening attendance. Therefore, months
10–15 will be spent collecting the data on screening at-
tendance and analysing the data. The training materials
will also be developed during this time. In months 16–17,
we will produce a final report and a paper of the main re-
sults for publication, and hold presentations on the results
for NHS Tayside staff.
Discussion
It is estimated that increasing breast cancer screening
uptake to the level found in higher socio-economic wo-
men (i.e. approximately 80%) across all socio-economic
groups could translate into approximately 49–57 add-
itional cancers diagnosed across Scotland annually, with
an extra 7–33 lives saved. This equates to a 20% increase
in the lowest uptake groups in Dundee. If this simple
telephone support intervention (with or without AR in-
tervention) leads to a significant increase in breast scree-
ning uptake, this would represent a rare example of a
theoretically-driven, relatively simple psychological in-
tervention that could result in earlier detection of breast
cancer amongst an under-served group of lower socio-
economic women.
This project has the full support of both the Scottish
Breast Screening Programme Board and the Detect
Cancer Early Programme. If the current trial proves a
clear advantage of the AR condition, it has the poten-
tial for implementation in the future National screen-
ing programme, e.g. by adding the AR questions to
the reminder letter. If the results of the trial are posi-
tive, they will be communicated immediately to Scottish
Breast Screening Programme Board, who will then ad-
vise the Scottish Government Department of Health
on implementation.
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aFor example, patients were sometimes concerned about
potential long-term dependence or negative effects of tak-
ing their medication; reassuring them that the medication
they were currently taking was not addictive, had been
used extensively over many years, and had not been found
to have serious side-effects over that time could help alle-
viate concerns and make patients less reluctant to take
their medicine.
bAt a national level for Scotland it is estimated that
this split would represent current screening attendance
rates of approximately 69% (vigintiles 1–12) versus 80%
(vigintiles 13–20).
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